These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 12797188)
1. Doppler study of the uterine artery in patients using an intrauterine contraceptive device. Momtaz M; Zayed M; Rashid K; Idriss O Ultrasound Obstet Gynecol; 1994 May; 4(3):231-4. PubMed ID: 12797188 [TBL] [Abstract][Full Text] [Related]
2. Uterine artery Doppler indices: pulsatility index and resistance index as predictive tools for the incidence of heavy menstrual bleeding related to copper intrauterine contraceptive device. Attia AM; Radwan ME; Elwan YA; Saleh HSA Obstet Gynecol Sci; 2021 May; 64(3):309-316. PubMed ID: 33736425 [TBL] [Abstract][Full Text] [Related]
3. The effect of the levonorgestrel intrauterine system on uterine artery blood flow 1 year after insertion. Haberal A; Kayikcioglu F; Gunes M; Kaplan M; Ozdegirmenci O Ultrasound Obstet Gynecol; 2006 Mar; 27(3):316-9. PubMed ID: 16450358 [TBL] [Abstract][Full Text] [Related]
4. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas. Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768 [TBL] [Abstract][Full Text] [Related]
5. The use of transvaginal ultrasonography compared to routine gynecological examination to check the location of an intrauterine contraceptive device. Granberg S; Bundsen P; Bourne TH; Almén M; Grenthe M; Leandersson R; Tönnberg C Ultrasound Obstet Gynecol; 1994 Jul; 4(4):316-9. PubMed ID: 12797167 [TBL] [Abstract][Full Text] [Related]
6. Effects of intrauterine device and oral contraceptive on vaginal flora and epithelium. Ocak S; Cetin M; Hakverdi S; Dolapcioglu K; Gungoren A; Hakverdi AU Saudi Med J; 2007 May; 28(5):727-31. PubMed ID: 17457440 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of transvaginal uterine Doppler assessment in an in vitro fertilization program. Favre R; Bettahar K; Grange G; Ohl J; Arbogast E; Moreau L; Dellenbach P Ultrasound Obstet Gynecol; 1993 Sep; 3(5):350-3. PubMed ID: 12797260 [TBL] [Abstract][Full Text] [Related]
8. Color Doppler sonographic study of the uterine artery in patients using intrauterine contraceptive devices. Frajndlich R; von Eye Corleta H; Frantz N J Ultrasound Med; 2000 Aug; 19(8):577-9. PubMed ID: 10944044 [TBL] [Abstract][Full Text] [Related]
9. Severity of pain and circadian changes in uterine artery blood flow in primary dysmenorrhea. Celik H; Gurates B; Parmaksiz C; Polat A; Hanay F; Kavak B; Yavuz A; Artas ZD Arch Gynecol Obstet; 2009 Oct; 280(4):589-92. PubMed ID: 19219445 [TBL] [Abstract][Full Text] [Related]
10. The effects of copper contraceptive intrauterine device on the uterine blood flow: A prospective transvaginal Doppler study. Yigit N; Kacar M; Yigit H; Kosar P; Kosar U J Clin Ultrasound; 2009 Sep; 37(7):380-4. PubMed ID: 19455700 [TBL] [Abstract][Full Text] [Related]
11. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Magalhães J; Aldrighi JM; de Lima GR Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488 [TBL] [Abstract][Full Text] [Related]
12. Effect of standing on non-pregnant uterine blood flow. Dickey RP; Hower JF; Matulich EM; Brown GT Ultrasound Obstet Gynecol; 1994 Nov; 4(6):480-7. PubMed ID: 12797129 [TBL] [Abstract][Full Text] [Related]
13. Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device? Neale R; Knight I; Keane F Int J STD AIDS; 2009 Jun; 20(6):423-4. PubMed ID: 19451330 [TBL] [Abstract][Full Text] [Related]
14. Primary dysmenorrhea and uterine blood flow: a color Doppler study. Altunyurt S; Göl M; Altunyurt S; Sezer O; Demir N J Reprod Med; 2005 Apr; 50(4):251-5. PubMed ID: 15916208 [TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of renal artery resistance and pulsatility indices in normal pregnant women. Dib FR; Duarte G; Sala MM; Ferriani RA; Berezowski AT Ultrasound Obstet Gynecol; 2003 Nov; 22(5):515-9. PubMed ID: 14618666 [TBL] [Abstract][Full Text] [Related]
16. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena) and depot-medroxyprogesterone acetate (Depo-Provera) on subendometrial microvascularisation and uterine artery blood flow. Dane B; Akca A; Dane C; Evcimen S; Cetin A Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):240-4. PubMed ID: 19565422 [TBL] [Abstract][Full Text] [Related]
18. Second-trimester uterine artery flow velocity waveform and oral glucose tolerance test as a means of predicting intrauterine growth retardation. Valensise H; Romanini C Ultrasound Obstet Gynecol; 1993 Nov; 3(6):412-6. PubMed ID: 12797242 [TBL] [Abstract][Full Text] [Related]
20. Actinomyces in cervical smears of women using the intrauterine device in Singapore. Kalaichelvan V; Maw AA; Singh K Contraception; 2006 Apr; 73(4):352-5. PubMed ID: 16531165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]